Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Apoptosis in development
- Delayed removal of interdigital webs
- Anti-APO-1-induced DNA ladder
- Synchronized apoptosis in a culture
- The death receptors
- Two CD95 signaling pathways
- Necrosis versus apoptosis
- 3D model of CD95 receptor
- CD95 DISC formation
- c-FLIP-L/S inhibit caspase-8 activation
- c-FLIP-L/S inhibit CD95-mediated apoptosis
- The CD95 signaling pathway in MCF7-Fas cells
- The immune response
- AICD upon TCR-restimulation
- IL-2 initiated switch regulates apoptosis sensitivity
- IL-2 is required for efficient apoptosis of d6 T cells
- Influence of IL-2 on DISC formation in d6 T cells
- Influence of IL-2 on mitochondria in d6 T cells
- CD95 resistance and sensitivity model in T cells
- CD28 reduces CD3 induced apoptosis
- CD28 costimulation upregulates c-FLIP-S in ATCs
- CD28 costimulation upregulates Bcl-xL in ATCs
- CD28 costimulation represses CD95L promoter
- Modulation of CD95 pathway by CD28
- Memory markers and subclasses of memory cells
- In vitro culture system
- Sensitivity of long-term T cells towards apoptosis
- Proliferation assay
- Determination of apoptosis: a healthy control
- Determination of apoptosis: a sepsis patient
- Septic patients lymphocytes are resistant to CD95
- Increased T-cell apoptosis in septic patients
- The T cell response defines survival in sepsis
- Why apoptosis?
- Rodent stroke model
- Abs for CD95L and TNF attenuate stroke damage
- Better locomotor response of Abs-treated animals
- Spinal cord injury and MRI diagnostics
- Spinal cord injury model
- MRI of injured mice
- Apoptosis after SCI
- Apoptosis decsreses by anti-CD95L-Ab
- Short-term experiments
- Swimming test
- Summary
- Swimming test after spinal cord injury in mice
- Dream of a tumor immunologist
- Killer cells meet a tumor cell
- Chemotherapy and p53-induced apoptosis (1)
- Mutations of the p53-gene
- p53 mutants do not transactivate the CD95-gene
- A model for the action of chemotherapeutic drugs
- Chemotherapy and p53-induced apoptosis (2)
- Tumor regression induced by anti-APO-1
Topics Covered
- Basics of apoptosis
- Signalling through death receptors
- Apoptosis in the immune system
- Apoptosis in diseases: sepsis, stroke and spinal cord injury
- Apoptosis and killer T cells
- Apoptosis and p53
- Apoptosis and cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Krammer, P. (2007, October 1). Apoptosis in the immune system [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/SZDV8392.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Peter Krammer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.